On the basis of correction for mutational background by considering only the NF2 mutant meningiomas, we calculated atypical tumours to have a 2.19 times greater risk to be CNV-high (P=0.001, Fisher’s exact test) (Supplementary Data 3b). This evidence concerns the gene NF2 and meningioma.